Palvella Therapeutics (PVLA) EBITDA Margin Growth (3y) (2017 - 2024)
Palvella Therapeutics (PVLA) EBITDA Margin Growth (3y) (2017 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Palvella Therapeutics |
1.49 Bn |
1.23 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2024 |
-512,261.00 |
| Sep 30, 2023 |
40,603.00 |
| Jun 30, 2023 |
6,383.00 |
| Mar 31, 2023 |
-66,849.00 |
| Sep 30, 2022 |
-380,894.00 |
| Jun 30, 2022 |
-7,483.00 |
| Mar 31, 2022 |
6,497.00 |
| Dec 31, 2021 |
174,747.00 |
| Sep 30, 2021 |
-50,098.00 |
| Jun 30, 2021 |
-63,592.00 |
| Mar 31, 2021 |
21,232.00 |
| Dec 31, 2020 |
-77,034.00 |
| Sep 30, 2020 |
-28,657.00 |
| Jun 30, 2020 |
53,633.00 |
| Mar 31, 2020 |
57,010.00 |
| Dec 31, 2019 |
16,721.00 |
| Sep 30, 2019 |
78,315.00 |
| Jun 30, 2019 |
30,746.00 |
| Mar 31, 2019 |
24,113.00 |
| Dec 31, 2018 |
-254,125.00 |
